The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ATRICURE INC | Equity | 04963C209 | 27,916 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
BIO-RAD LABORATORIES-A | Equity | 090572207 | 36,670 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CORREVIO PHARMA CORP | Equity | 22026V105 | 1,019 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
CRL US 01/17/20 C140 | Listed Option | 159864907 | 279 | 218 | SH | Call | SOLE | 218 | 0 | 0 | |
QUEST DIAGNOSTICS INC | Equity | 74834L100 | 25,745 | 245,000 | SH | SOLE | 245,000 | 0 | 0 | ||
HAE US 01/17/20 C125 | Listed Option | 405024900 | 24 | 500 | SH | Call | SOLE | 500 | 0 | 0 | |
HOLOGIC INC | Equity | 436440101 | 24,648 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
ICU MEDICAL INC | Equity | 44930G107 | 12,985 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
INOGEN INC | Equity | 45780L104 | 4,976 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
IVERIC BIO INC | Equity | 46583P102 | 21,571 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
INTEGER HOLDINGS CORP | Equity | 45826H109 | 13,367 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
JOHNSON & JOHNSON | Equity | 478160104 | 18,035 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
JNJ US 01/17/20 C140 | Listed Option | 478160904 | 125 | 250 | SH | Call | SOLE | 250 | 0 | 0 | |
LANTHEUS HOLDINGS INC | Equity | 516544103 | 12,474 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
ALLSCRIPTS HEALTHCARE SOLUTI | Equity | 01988P108 | 35,150 | 3,650,000 | SH | SOLE | 3,650,000 | 0 | 0 | ||
MEDTRONIC PLC | Equity | 585055106 | 43,844 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
MYLAN NV | Equity | 628530107 | 9,090 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
NEVRO CORP | Equity | 64157F103 | 4,720 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
OPTINOSE INC | Equity | 68404V100 | 8,568 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
PACIRA BIOSCIENCES INC | Equity | 695127100 | 27,813 | 622,500 | SH | SOLE | 622,500 | 0 | 0 | ||
PHREESIA INC | Equity | 71944F106 | 17,549 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | Equity | 737010108 | 14,268 | 595,000 | SH | SOLE | 595,000 | 0 | 0 | ||
RADNET INC | Equity | 750491102 | 8,268 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | Equity | 766559603 | 11,788 | 5,750,000 | SH | SOLE | 5,750,000 | 0 | 0 | ||
SPY US 01/17/20 P310 | Listed Option | 78462F953 | 512 | 8,000 | SH | Put | SOLE | 8,000 | 0 | 0 | |
STERICYCLE INC | Equity | 858912108 | 18,591 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
STREAMLINE HEALTH SOLUTIONS | Equity | 86323X106 | 5,985 | 4,305,882 | SH | SOLE | 4,305,882 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | Equity | 91307C102 | 13,090 | 151,400 | SH | SOLE | 151,400 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | Equity | 98956P102 | 18,594 | 125,000 | SH | SOLE | 125,000 | 0 | 0 |